Nature Communications (Jan 2020)

Rational design of universal immunotherapy for TfR1-tropic arenaviruses

  • Hadas Cohen-Dvashi,
  • Ron Amon,
  • Krystle N. Agans,
  • Robert W. Cross,
  • Aliza Borenstein-Katz,
  • Mathieu Mateo,
  • Sylvain Baize,
  • Vered Padler-Karavani,
  • Thomas W. Geisbert,
  • Ron Diskin

DOI
https://doi.org/10.1038/s41467-019-13924-6
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 11

Abstract

Read online

New World arenaviruses utilize the cellular transferrin receptor 1 (TfR1) to enter host cells. Here, the authors develop a TfR1-mimetic immunoadhesin, Arenacept, that targets viral spike complexes and exerts effective pan-reactive neutralization against pathogenic mammarenaviruses.